Former head of CMS predicts 'chaos' at agency

Why This Topic Matters

The article helps readers understand why CMS policy changes under MMA were expected to affect Medicare drug coverage, plan participation, and payment decisions across the health care market. It is relevant for organizations tracking Medicare reimbursement, managed care options, and drug benefit administration.

Article Sections

1. CMS and MMA implementation outlook

   Overview of how the new Medicare law was expected to expand CMS’s role and create implementation challenges over the near term.

2. Conference remarks and market impact

   Summary of comments made at an industry conference about spending expectations, plan participation, and the competitive response from companies in the Medicare market.

3. ASP model could change, Scully predicts

   Discussion of a possible shift in Medicare drug reimbursement policy and alternative approaches mentioned for office-administered drugs.